The non-muscle-invasive bladder carcinoma cell line 5637 has been used as an in vitro model for high-risk superficial bladder tumors with specific molecular characteristics (Bcl-2 and Bcl-X positive expression and P53 tumor suppressor mutation) [9]. The gene discussed is BCL2; the disease is neoplasm.